These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33261990)

  • 41. The transforming growth factor-beta/bone morphogenetic protein signalling pathway in adipogenesis.
    Margoni A; Fotis L; Papavassiliou AG
    Int J Biochem Cell Biol; 2012 Mar; 44(3):475-9. PubMed ID: 22226816
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Common Cell Lines Used to Study Bone Morphogenetic Proteins (BMPs).
    Cottrell JA; Burgess D; Michaels S; Rogers MB
    Methods Mol Biol; 2019; 1891():1-8. PubMed ID: 30414121
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Smad2 is essential for maintenance of the human and mouse primed pluripotent stem cell state.
    Sakaki-Yumoto M; Liu J; Ramalho-Santos M; Yoshida N; Derynck R
    J Biol Chem; 2013 Jun; 288(25):18546-60. PubMed ID: 23649632
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Overexpression of Latent TGFβ Binding Protein 4 in Muscle Ameliorates Muscular Dystrophy through Myostatin and TGFβ.
    Lamar KM; Bogdanovich S; Gardner BB; Gao QQ; Miller T; Earley JU; Hadhazy M; Vo AH; Wren L; Molkentin JD; McNally EM
    PLoS Genet; 2016 May; 12(5):e1006019. PubMed ID: 27148972
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bone Morphogenetic Proteins: Promising Molecules for Bone Healing, Bioengineering, and Regenerative Medicine.
    Carreira AC; Zambuzzi WF; Rossi MC; Astorino Filho R; Sogayar MC; Granjeiro JM
    Vitam Horm; 2015; 99():293-322. PubMed ID: 26279381
    [TBL] [Abstract][Full Text] [Related]  

  • 46. GDF11 promotes osteogenesis as opposed to MSTN, and follistatin, a MSTN/GDF11 inhibitor, increases muscle mass but weakens bone.
    Suh J; Kim NK; Lee SH; Eom JH; Lee Y; Park JC; Woo KM; Baek JH; Kim JE; Ryoo HM; Lee SJ; Lee YS
    Proc Natl Acad Sci U S A; 2020 Mar; 117(9):4910-4920. PubMed ID: 32071240
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Triggering TGFbeta and notch signalling cross-talk.
    Soares R; Alçada MN; Azevedo I
    Bioessays; 2005 Jul; 27(7):763. PubMed ID: 15954101
    [No Abstract]   [Full Text] [Related]  

  • 48. Activin/TGFbeta and BMP crosstalk determines digit chondrogenesis.
    Montero JA; Lorda-Diez CI; Gañan Y; Macias D; Hurle JM
    Dev Biol; 2008 Sep; 321(2):343-56. PubMed ID: 18602912
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Regulatory roles of transforming growth factor beta family members in folliculogenesis.
    Myers M; Pangas SA
    Wiley Interdiscip Rev Syst Biol Med; 2010; 2(1):117-125. PubMed ID: 20836015
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interaction of TGFβ and BMP signaling pathways during chondrogenesis.
    Keller B; Yang T; Chen Y; Munivez E; Bertin T; Zabel B; Lee B
    PLoS One; 2011 Jan; 6(1):e16421. PubMed ID: 21297990
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tbx2 mediates dorsal patterning and germ layer suppression through inhibition of BMP/GDF and Activin/Nodal signaling.
    Reich S; Kayastha P; Teegala S; Weinstein DC
    BMC Mol Cell Biol; 2020 May; 21(1):39. PubMed ID: 32466750
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regulation of Smad activity.
    Wrana JL
    Cell; 2000 Jan; 100(2):189-92. PubMed ID: 10660041
    [No Abstract]   [Full Text] [Related]  

  • 53. Asymmetric activation of Dll4-Notch signaling by Foxn4 and proneural factors activates BMP/TGFβ signaling to specify V2b interneurons in the spinal cord.
    Misra K; Luo H; Li S; Matise M; Xiang M
    Development; 2014 Jan; 141(1):187-98. PubMed ID: 24257627
    [TBL] [Abstract][Full Text] [Related]  

  • 54. TGF-β, Bone Morphogenetic Protein, and Activin Signaling and the Tumor Microenvironment.
    Pickup MW; Owens P; Moses HL
    Cold Spring Harb Perspect Biol; 2017 May; 9(5):. PubMed ID: 28062564
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Signal transduction pathway through activin receptors as a therapeutic target of musculoskeletal diseases and cancer.
    Tsuchida K; Nakatani M; Uezumi A; Murakami T; Cui X
    Endocr J; 2008 Mar; 55(1):11-21. PubMed ID: 17878607
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Combinatorial signals of activin/nodal and bone morphogenic protein regulate the early lineage segregation of human embryonic stem cells.
    Wu Z; Zhang W; Chen G; Cheng L; Liao J; Jia N; Gao Y; Dai H; Yuan J; Cheng L; Xiao L
    J Biol Chem; 2008 Sep; 283(36):24991-5002. PubMed ID: 18596037
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical significance linked to functional defects in bone morphogenetic protein type 2 receptor, BMPR2.
    Kim MJ; Park SY; Chang HR; Jung EY; Munkhjargal A; Lim JS; Lee MS; Kim Y
    BMB Rep; 2017 Jun; 50(6):308-317. PubMed ID: 28391780
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bone morphogenetic protein signaling in musculoskeletal cancer.
    Bami M; Mavrogenis AF; Angelini A; Milonaki M; Mitsiokapa E; Stamoulis D; Soucacos PN
    J Cancer Res Clin Oncol; 2016 Oct; 142(10):2061-72. PubMed ID: 27043154
    [TBL] [Abstract][Full Text] [Related]  

  • 59. BMP and TGFbeta pathways in human central chondrosarcoma: enhanced endoglin and Smad 1 signaling in high grade tumors.
    Boeuf S; Bovée JV; Lehner B; van den Akker B; van Ruler M; Cleton-Jansen AM; Richter W
    BMC Cancer; 2012 Oct; 12():488. PubMed ID: 23088614
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Physiological role of bone morphogenetic proteins in osteogenesis.
    Kugimiya F; Ohba S; Nakamura K; Kawaguchi H; Chung UI
    J Bone Miner Metab; 2006; 24(2):95-9. PubMed ID: 16502114
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.